HealthDay Now: The ‘Path Towards a Cure’ for Diabetes at ADA 2022

As the American Diabetes Association concluded its 82nd Scientific Sessions, HealthDay’s Mabel Jong was joined by Dr. Robert Gabbay, the ADA’s chief scientific and medical officer. Dr. Gabbay discussed highlights from the conference, including new drugs and devices, the relationship between diabetes and COVID-19, and how much progress has been made in the path towards a cure.